Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,594.00    28.00 (0.61%)
Bid:
4,592.00
Ask:
4,594.00
Spread: 2.00 (0.044%)
Market Cap: £16.74b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director/PDMR Shareholding

18 Mar 2021 12:52

RNS Number : 7526S
Coca-Cola HBC AG
18 March 2021
Β 

FOR IMMEDIATE RELEASE

18 March 2021

Β 

Coca-Cola HBC AG (the "Company")

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs')

The Company has been notified that the following PDMR has been granted at nil cost performance shares of CHF 6.70 each ("Shares") in the Company on 16 March 2021 through his participation in the Stock Option and Performance Share Award Plan ("PSP"). The performance shares will vest as described below subject to achievement of performance conditions.

Β PDMR

Number of Shares granted under the PSP

Share price

BEN ALMANZAR

19,884

Β£ 23.80

Β 

The Notification of Dealing Forms for each PDMR can be found below.

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

a)

Β 

Name

Β 

BEN ALMANZAR

2

Β 

Reason for the notification

a)

Β 

Position/status

Β 

INCOMING CHIEF FINANCIAL OFFICER

b)

Β 

Initial notification /Amendment

Β 

INITIAL NOTIFICATION

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Β 

Name

Β 

COCA-COLA HBC AG

b)

Β 

LEI

Β 

549300EFP3TNG7JGVE49

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

SHARES

Β 

Β 

CH0198251305

b)

Β 

Nature of the transaction

Β 

Β 

GRANTING OF PERFORMANCE SHARES AT NIL COST WHICH WILL VEST AFTER ONE YEAR SUBJECT TO ACHIEVEMENT OF PERFORMANCE CONDITIONS OF THE 2019-2021 PERFORMANCE SHARE PLAN

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Volume(s)

23.80 GBP

9,942

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Price

Volume

Total

23.80 GBP

9,942

236,619.60 GBP

e)

Β 

Date of the transaction

Β 

2021-03-16

f)

Β 

Place of the transaction

Β 

OUTSIDE A TRADING VENUE

Β 

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

SHARES

Β 

Β 

CH0198251305

b)

Β 

Nature of the transaction

Β 

Β 

GRANTING OF PERFORMANCE SHARES AT NIL COST WHICH WILL VEST AFTER TWO YEARS SUBJECT TO ACHIEVEMENT OF PERFORMANCE CONDITIONS OF THE 2020-2022 PERFORMANCE SHARE PLAN

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Volume(s)

23.80 GBP

9,942

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Price

Volume

Total

23.80 GBP

9,942

236,619.60 GBP

e)

Β 

Date of the transaction

Β 

2021-03-16

f)

Β 

Place of the transaction

Β 

OUTSIDE A TRADING VENUE

Β 

Β 

This notification is made in accordance with the requirements of the EU Market Abuse Regulation.

For further information, please contact:

Jan Gustavsson

General Counsel and Company Secretary

+41 (0) 41 726 01 37

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHDKFBQBBKDCND
Date   Source Headline
15th Jun 20265:00 pmRNSDirector/PDMR Shareholding
22nd May 20263:30 pmRNSDirector/PDMR Shareholding
19th May 20263:15 pmRNSDirector/PDMR Shareholding
11th May 20269:00 amRNSDirector Declaration
8th May 20263:15 pmRNSComposition of the Board Committees
8th May 20263:10 pmRNSResult of AGM
7th May 20267:00 amRNSStrong volume drives Q1 sales growth
20th Apr 20263:15 pmRNSDirector/PDMR Shareholding
14th Apr 202612:15 pmRNSNotice of Results
2nd Apr 20267:00 amRNSNotice of AGM, changes to the BoD, dividend dates
1st Apr 20269:15 amRNSTransfer of treasury shares & total voting rights
31st Mar 202611:00 amRNSPublication of Final Terms
27th Mar 20262:45 pmRNSDirector/PDMR Shareholding
27th Mar 20262:15 pmRNSDirector/PDMR Shareholding
26th Mar 20266:18 pmRNSPricing of Issue of Notes
26th Mar 20269:05 amRNSLaunch of Issue of Notes
25th Mar 20261:36 pmRNSPublication of a Prospectus
20th Mar 202611:00 amRNSAnnual Financial Report
19th Mar 20264:55 pmRNSDirector/PDMR Shareholding
19th Mar 20264:45 pmRNSDirector/PDMR Shareholding
18th Mar 20264:15 pmRNSDirector/PDMR Shareholding
18th Mar 202611:35 amRNSDirector/PDMR Shareholding
26th Feb 202611:30 amRNSDirector/PDMR Shareholding
25th Feb 20269:20 amRNSDirector/PDMR Shareholding
24th Feb 20264:55 pmRNSDirector/PDMR Shareholding
24th Feb 20264:50 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:40 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:35 pmRNSDirector/PDMR Shareholding
18th Feb 20264:50 pmRNSDirector/PDMR Shareholding
18th Feb 20264:45 pmRNSDirector/PDMR Shareholding
18th Feb 20264:00 pmRNSDirector/PDMR Shareholding
17th Feb 20263:35 pmRNSDirector/PDMR Shareholding
17th Feb 20263:30 pmRNSDirector/PDMR Shareholding
16th Feb 20262:40 pmRNSDirector/PDMR Shareholding
16th Feb 20262:35 pmRNSDirector/PDMR Shareholding
13th Feb 202610:30 amRNSDirector/PDMR Shareholding
12th Feb 20263:45 pmRNSDirector/PDMR Shareholding
12th Feb 20261:15 pmRNSDirector/PDMR Shareholding
10th Feb 20267:00 amRNSStrong execution and financial performance in 2025
2nd Feb 202610:00 amRNSTransfer of treasury shares & total voting rights
19th Jan 20264:00 pmRNSDirector/PDMR Shareholding
19th Jan 20262:20 pmRNSResult of Extraordinary General Meeting
13th Jan 202611:00 amRNSNotice of Results
5th Jan 202610:00 amRNSDirector/PDMR Shareholding
23rd Dec 20252:45 pmRNSDirector/PDMR Shareholding
23rd Dec 20252:45 pmRNSDirector/PDMR Shareholding
22nd Dec 20252:15 pmRNSDirector/PDMR Shareholding
22nd Dec 20252:15 pmRNSDirector/PDMR Shareholding
18th Dec 20255:00 pmRNSDirector/PDMR Shareholding
18th Dec 20255:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.